Search

everythinglearnresearchcommunity

for

Search:↓

Some skin medications are safe during pregnancy and breastfeeding, but others can harm the baby and should be avoided.

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.

Inflammation may be linked to hair loss, and targeting specific enzymes could help treat it.

Medications have become the main treatment for enlarged prostate symptoms, replacing surgery and watchful waiting.

Hormones significantly affect hair and oil gland function in the skin, and more research is needed on skin-related hormone disorders.

Cholesterol sulfate buildup due to a genetic mutation disrupts the skin barrier, leading to the scaling skin seen in X-linked ichthyosis.

Some common medications can harm male fertility, but many effects can be reversed.

Female pattern hair loss can be treated with medications, surgery, and cosmetic products, considering its psychological impact.

Dutasteride and finasteride do not significantly affect bone density, blood fats, or blood production, but slightly lower PSA levels and minimally impact sexual function in healthy young men.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.

Brain hormones significantly affect hair color and could potentially be used to prevent or reverse grey hair.

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

Maintaining the right amount of retinoic acid is crucial for healthy hair and skin.

Use "female pattern hair loss" term, assess androgen excess, treat with minoxidil and other medications if needed.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Female pattern hair loss diagnosed by scalp appearance, treated with combined therapies and targeted approaches.

Systemic glucocorticosteroids are a primary treatment for various skin conditions but require careful management due to potential side effects and relapses.

Some hormone-related drugs may protect brain cells in Parkinson's disease differently in men and women.

Finasteride given to baby rats causes anxiety-like behavior and worsens learning from punishment in adult rats.

Mutations in certain receptors can cause diseases and offer new treatment options.

Hair regrowth slows with age and can be affected by treatments that change enzyme activity in the skin.

Different anti-androgen medications can help treat excessive hair growth, but the right choice depends on accurate diagnosis.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

Cholesterol-related compounds can stop hair growth and cause inflammation in a type of scarring hair loss.

Hair loss from genetics and hormones can be treated with drugs or surgery.

Aging scalp skin contributes to hair aging and loss, and more research is needed to develop better hair loss treatments.

Some alternative vitiligo treatments show promise, but none are as effective as psoralens and UVA.

PDRN, derived from salmon sperm, shows promise in healing wounds, reducing inflammation, and regenerating tissues, but more research is needed to understand its mechanisms and improve its use.